Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,238,461
+$798,312 QoQ
Shares Held
2,700
+1.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#2,056
of 4,605 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financial Engines Advisors L.L.C. holds $32,908,375 across 9 Drug Manufacturers - General names. LLY ranks #2 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
83,818 | $21,091,961 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
2,700 | $3,238,461 | |
| 3 | JNJ |
Johnson & Johnson
|
12,305 | $3,125,100 | |
| 4 | AMGN |
Amgen Inc
|
5,295 | $1,917,425 | |
| 5 | MRK |
Merck & Co., Inc.
|
8,510 | $1,093,535 | |
| 6 | NVS |
Novartis AG
|
6,697 | $1,049,553 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,130 | $526,070 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,619 | $457,224 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,238,461 | 2,700 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,440,149 | 2,653 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,296,043 | 3,067 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,275,266 | 2,982 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,690,800 | 2,169 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $771,399 | 934 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,137,928 | 1,474 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,460,915 | 1,649 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,355,353 | 1,497 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,103,147 | 1,418 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $719,323 | 1,234 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $557,540 | 1,038 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $393,943 | 840 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $282,291 | 822 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $848,382 | 2,319 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $707,489 | 2,188 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $938,645 | 2,895 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $609,968 | 2,130 | Shares | Sole | 2022-05-12 | |
| 2021-09-30 | $422,821 | 1,830 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $336,246 | 1,465 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $262,855 | 1,407 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $223,713 | 1,325 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $233,871 | 1,580 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||